HCPCS Level II
J7639
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Codes near J7639
These sit next to J7639 in the CMS Level II file. All J codes
- J7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
- J7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
- J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
- J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50242-0100-40 | Pulmozyme | Genentech, Inc. | 75 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.